Skip to content
My WebMD Sign In, Sign Up

Brain & Nervous System Health Center

Font Size
A
A
A

FDA OKs Generic Requip

Approval Announced for Generic Versions of Requip Made by 4 Different Companies
By
WebMD Health News
Reviewed by Louise Chang, MD

FDA Generic Requip

May 14, 2008 -- The FDA has approved generic versions of the drug Requip made by four companies.

Generic ropinirole hydrochloride will be made by Teva Pharmaceuticals USA, Roxane Laboratories, Mylan Pharmaceuticals, and Par Pharmaceutical.

Requip, made by GlaxoSmithKline, is used to treat restless legs syndrome and Parkinson's disease. Requip's patent expires on May 19, according to the FDA.

Restless legs syndrome (RLS) is a disorder in which people have an unpleasant feeling in their legs when lying down to sleep; they often have a strong urge to move their legs, making it difficult to sleep.

Parkinson's is a progressive disease in which there is a breakdown in the nerve cells in the brain that make dopamine. Symptoms include tremors, stiff muscles, slow movement, and problems with balance or walking.

Today on WebMD

Depressed
Slideshow
3d scan of fractured skull
Slideshow
 
human brain waves
Article
brain maze
fitQuiz
 
senior man
Article
brain research briefing
Article
 
Syringe
Article
graphic of human head
Article
 
mans hands on laptop keyboard
Article
brain illustration stroke
Slideshow
 
most common stroke symptoms
Article
Parkinsons Disease Medications
Article